AMY HULL: Open Payments
NPI 1972553527 · LOCUST GROVE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 31 payments from 8 companies in 2025. Trend: 2023 $565 · 2024 $744 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $167 |
| ABBVIE INC. | 18 | $160 |
| AstraZeneca Pharmaceuticals LP | 1 | $148 |
| PFIZER INC. | 3 | $74 |
| Amgen Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: FARXIGA, QULIPTA, UBRELVY, NURTEC ODT, OTEZLA, RECORLEV, XIFAXAN, PREVNAR 20.
Industry payments across VA — which companies pay providers there.
